The anti-inflammatory drug colchicine, usually used to treat gout, will be included in the UK’s nationwide RECOVERY trial program aimed at seeking a cure for the coronavirus infection, its researchers have said.
Colchicine will be tested in a randomized trial involving 2,500 patients across the UK who will receive the drug in addition to the existing standard of care for a total of 10 days, the RECOVERY (Randomised Evaluation of Covid-19 Therapy) program said on its website.
Continue reading https://on.rt.com/aw0n